Human Papillomavirus Infections Therapeutics Market Clinical Trials H2 2014 Review Research Report

DALLAS, February 25, 2015 /PRNewswire/ --

ReportsnReports.com adds "Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014" to its store. This report provides data on clinical trial scenario of the Human Papillomavirus Infections.

The clinical trial report "Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014″ provides data on the Human Papillomavirus Infections clinical trial scenario. Human Papillomavirus Infections is the most common sexually transmitted infection. It is an infection that is passed between people through skin-to-skin contact. High-risk Human Papillomavirus infection accounts for approximately 5 percent of all cancers worldwide. In the majority of cases, HPV infection has no noticeable signs or symptoms. Signs and symptoms are genital warts, common warts, plantar warts and flat warts. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Human Papillomavirus Infections. This report also provide data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

The report also includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Companies discussed in this clinical trials report includes Merck & Co., Inc., GlaxoSmithKline plc, Medicis Pharmaceutical Corporation, BioMAS Ltd., AstraZeneca PLC, Novartis AG, MediGene AG, Meda AB, Genticel S.A., G&E Herbal Biotechnology Co., Ltd.

This report also includes the clinical trial overview of top institutes and government that includes The National Institute of Allergy and Infectious Diseases, National Cancer Institute, Johns Hopkins University, University of Pittsburgh, The University of Hong Kong, Leiden University Medical Center, Medical University of Vienna, AIDS Malignancy Clinical Trials Consortium, The Alfred Hospital, The University of Sydney. Order a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=320860 . (This is a premium report priced at US$2500 for a single user License.)

Featured News & Press Releases cover by this report include: Nov 18, 2014: Researchers Pioneer New Approach To Treating HPV-Related Cervical Cancer; Nov 13, 2014: Genticel completes ProCervix Phase II study enrollment ahead of schedule; Nov 04, 2014: Cevira data published in American Journal of Obstetrics & Gynecology; Oct 30, 2014: Genexine's HPV Therapeutic Vaccine Achieved High Efficacy in Phase I Cervical Dysplasia Trial; Oct 10, 2014: Results of the Cevira Phase 2b presented at DGGG 35
Oct 08, 2014: Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine; Sep 22, 2014: Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers.

Reasons to buy 

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

More related reports on Clinical Trials:

Human Papillomavirus Infections - Pipeline Review, H2 2014 

This report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections and special features on late-stage and discontinued projects.

Companies discussed in this Onchocerciasis (River Blindness) clinical trials report include Merck & Co., Inc., Takeda Pharmaceutical Company Limited, MediGene AG, Chong Kun Dang Pharmaceutical Corp., Crucell N.V., Starpharma Holdings Limited, Bharat Biotech International Limited, FluGen, Inc., Genticel, Vaxart, Inc., Selecta Biosciences, Inc., Spider Biotech, Indian Immunologicals Limited, Beijing Minhai Biotechnology Co., Ltd, Shanghai Zerun Biotechnology Co., Ltd., Chongqing Zhifei Biological Products Co., Ltd., Immunservice GmbH, Redbiotec AG, Agilvax, Inc., Nielsen Biosciences, Inc. Complete report available @ http://www.reportsnreports.com/reports/311349-human-papillomavirus-infections-pipeline-review-h2-2014.html .

HIV-2 Infection Global Clinical Trials Review, H2, 2014 

This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-2 Infection. Companies and Institutes discussed in this report includes GlaxoSmithKline plc, Merck & Co., Inc, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., C. H. Boehringer Sohn AG & Co. KG, Abbott Laboratories, AbbVie Inc., BioCryst Pharmaceuticals, Inc., The National Institute of Allergy and Infectious Diseases, French National Agency for Research on AIDS and Viral Hepatitis, University of California, San Francisco, Centers for Disease Control and Prevention, National Center for Complementary and Alternative Medicine, Emory University, University of Washington, Hospital Clinic de Barcelona, University of Miami, Stanford University. Complete report details @ http://www.reportsnreports.com/reports/320859-hiv-2-infection-global-clinical-trials-review-h2-2014.html .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts  

Twitter: http://twitter.com/marketsreports

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel:  +1-888-391-5441
[email protected]

SOURCE ReportsnReports